Efficacy of a Novel Fluoride Varnish in Preventing WSL During/After Treatment With Fixed Orthodontic Appliances
1 other identifier
interventional
180
0 countries
N/A
Brief Summary
The aim of the present study is to evaluate the efficacy of a novel fluoride varnish (NFV) in preventing white spot lesion development in adolescents during and after treatment with fixed orthodontic appliances.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2014
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 29, 2018
CompletedFirst Posted
Study publicly available on registry
October 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedNovember 6, 2018
November 1, 2018
4.6 years
October 29, 2018
November 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome will be incidence of white spot lesions on the labial surfaces of the maxillary incisors, canines and premolars
Assessed from high-resolution digital photos
12-24 months
Secondary Outcomes (1)
The secondary outcome is the prevalence of WSLs at debonding and one year after debond
12 months
Study Arms (2)
Fluoride varnish
EXPERIMENTALDuring the course of the orthodontic treatment, the patients are regularly checked every 6th week. At the end of each such occasion, the clinical staff will apply the test varnish with a small brush in a thin layer around the base of the braces on the maxillary teeth. The varnish is let to dry and the subjects are instructed not to eat or drink within 60 minutes after the application. The NFV test varnish has mint flavour and the active ingredient is ammonium fluoride dissolved in ethanol, water and an acrylate polymer.
Varnish without Fluoride
PLACEBO COMPARATORDuring the course of the orthodontic treatment, the patients are regularly checked every 6th week. At the end of each such occasion, the clinical staff will apply either the placebo varnish with a small brush in a thin layer around the base of the braces on the maxillary teeth. The varnish is let to dry and the subjects are instructed not to eat or drink within 60 minutes after the application. The placebo varnish has an identical composition as the test varnish except for the ammonium fluoride. Thus, taste, colour and handling properties are the same.
Interventions
The study will employ a double-blind, randomized placebo-controlled design with two parallel groups. The intervention will start at onset of the fixed appliances and will be finalized one year after debond. The primary outcome will be incidence of white spot lesions on the labial surfaces of the maxillary incisors, canines and premolars, as assessed from high-resolution digital photos. The secondary outcome is the prevalence of WSLs at debonding.
Eligibility Criteria
You may not qualify if:
- In the event of long-term prescriptions of general antibiotics during the course of the study, this should be recorded separately
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malmö Universitylead
- University of Copenhagencollaborator
Related Publications (2)
Sonesson M, Brechter A, Lindman R, Abdulraheem S, Twetman S. Fluoride varnish for white spot lesion prevention during orthodontic treatment: results of a randomized controlled trial 1 year after debonding. Eur J Orthod. 2021 Aug 3;43(4):473-477. doi: 10.1093/ejo/cjaa055.
PMID: 33009565DERIVEDSonesson M, Brechter A, Abdulraheem S, Lindman R, Twetman S. Fluoride varnish for the prevention of white spot lesions during orthodontic treatment with fixed appliances: a randomized controlled trial. Eur J Orthod. 2020 Jun 23;42(3):326-330. doi: 10.1093/ejo/cjz045.
PMID: 31197364DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Mikael Sonesson, Odont. Dr.
Malmö University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
October 29, 2018
First Posted
October 30, 2018
Study Start
June 1, 2014
Primary Completion
December 31, 2018
Study Completion
December 31, 2019
Last Updated
November 6, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share